Saudi Journal of Gastroenterology

: 1997  |  Volume : 3  |  Issue : 2  |  Page : 70--73

Primary prophylaxis for bleeding from esophageal varices

Indrajit Tiwari 
 Department of Internal Medicine, Armed Forces Hospital, Southern Region, P.O. Box 101, Khamis Mushayt, Saudi Arabia

Correspondence Address:
Indrajit Tiwari
361 Chelsea Cloisters, Sloane Avenue, London SW 3 3DW, United Kingdom

Esophageal varices develop in 30-70% of patients with liver cirrhosis. One-third of these varices will eventually bleed and first episode could be fatal in 40-50% of patients. Because of this, primary prophylaxis can be justified if patients at high risk of bleeding can be identified. Many endoscopic findings can identify the patients likely to bleed in near future. The results of primary prophylaxis with portacaval shunts and endoscopic sclerotherapy have been disappointing. Nonselective betablockers have been found effective in preventing bleeding from varices and their use is justified for this purpose.

How to cite this article:
Tiwari I. Primary prophylaxis for bleeding from esophageal varices.Saudi J Gastroenterol 1997;3:70-73

How to cite this URL:
Tiwari I. Primary prophylaxis for bleeding from esophageal varices. Saudi J Gastroenterol [serial online] 1997 [cited 2021 Jan 22 ];3:70-73
Available from:;year=1997;volume=3;issue=2;spage=70;epage=73;aulast=Tiwari;type=0